Optimi Health completes latest production batch of MDMA finished drug product; Phase 3 trial expected to begin in 2027

Optimi Health Corp. says it completed its latest production batch of MDMA finished drug product. The company's proposed Phase 3 trial is expected to begin in 2027.

Detected & updated continuously · Source: Nebula